Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 794-801

  Peijnenburg, Ad ^a   Van Eggermond, Marja J C A ^a   Gobin, Sam J P ^a   Van Den Berg, Rian ^a   Godthelp, Barbara C ^a   Vossen, Jaak M J J ^a   Van Den Elsen, Peter J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION;

ALLELES; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL FUSION; CELL MEMBRANE; CODON, TERMINATOR; DNA-BINDING PROTEINS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; GENETIC COMPLEMENTATION TEST; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; MALE; NUCLEAR PROTEINS; POINT MUTATION; SEVERE COMBINED IMMUNODEFICIENCY; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0033565743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Saito, T., and R. N. Germain. 1988. The molecular basis of MHC-restricted antigen recognition by T cells. Int. Rev. Immunol. 3:147.
2. Reith, W., V. Steimle, and B. Mach. 1995. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol. Today 16: 539.
3. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
4. Bénichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285.
5. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
6. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
7. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
8. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J.-C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273.
9. Nagarajan, U., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of bare lymphocyte syndrome, a MHC class II immunodeficiency. Immunity 10:153.
10. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
11. Durand, B., P. Sperisen, P. Emery, E. Barra, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in class II deficiency. EMBO J. 16:1045.
12. Moreno, C. S., E. M. Rogers, J. A. Brown, and J. M. Boss. 1997. Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158:5841.
13. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class II transcription. Annu. Rev. Immunol. 10:13.
14. Ting, J. P.-Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
15. Van den Elsen, P. J., S. J. P. Gobin, M. C. J. A. Van Eggermond, and A. Peijnenburg. 1998. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 48:208.
16. Van den Elsen, P. J., A. Peijnenburg, M. C. J. A. Van Eggermond, and S. J. P. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 19:308.
17. Reith, W., S. Satola, C. Herrero Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897.
18. Hasegawa, S. L., and J. M. Boss. 1991. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res. 19:6269.
19. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
20. Zeleznik-Le, N., J. C. Azizkhan, and J. P.-Y. Ting. 1991. Affinity purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873.
21. Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. B. Clarke, and J. P.-Y. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042.
22. Reith, W., C.-A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
23. Louis-Plence, P. L., C. S. Moreno, and J. M. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein nuclear factor-Y multiprotein complex on the conserved regulatory regions on HLA class II genes. J. Immunol. 159:3899.
24. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoter in the bare lymphocyte syndrome. Science 252:709.
25. Kara, C. J., and L. H. Glimcher. 1993. Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics 37:227.
26. Brown, A. M., K. L. Wright, and J. P.-Y. Ting. 1993. Human major histocompatibility complex class II-associated invariant chain gene promoter: functional analysis and in vivo protein/DNA interactions of constitutive and IFN-γ-induced expression. J. Biol. Chem. 268:26328.
27. Linhoff, M. W., K. L. Wright, and J. P.-Y. Ting. 1997. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell. Biol. 17:4589.
28. 2-microglobulin genes. Immunity 9:531.
29. Peijnenburg, A., S. J. P. Gobin, M. C. J. A. Van Eggermond, B. C. Godthelp, N. Van Graafeiland, and P. J. Van den Elsen. 1997. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression. J. Immunol. 159:2720.
30. Lisowska-Grospierre, B., M.-C. Fondaneche, M.-P. Rols, C. Griscelli, and A. Fischer. 1994. Two complementation groups account for most cases of inherited MHC class II deficiency. Hum. Mol. Genet. 3:953.
31. Godthelp, B., M. J. Van Tol, J. M. Vossen, and P. J. Van den Elsen. 1998. Long-term T cell immune reconstitution in 2 SCID patients after BMT. Hum. Immunol. 59:225.
32. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
33. Gobin, S. J. P., A. Peijnenburg, V. Keijsers, and P. J. van den Elsen. 1997. Site o is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601.
34. Barr, C. L., and G. F. Saunders. 1991. Interferon-γ-inducible regulation of the human invariant chain gene. J. Biol. Chem. 266:3475.
35. Brown, A. M., K. L. Wright, and J. P.-Y. Ting. 1993. Human major histocompatibility complex class II-associated invariant chain gene promoter. J. Biol. Chem. 268:26328.
36. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745.
37. Rebai, N., B. Malissen, M. Pierres, R. S. Accolla, G. Corte, and C. Mawas. 1983. Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies either DR or allo-anti-la crossreacting with human DR. Eur. J. Immunol. 13:106.
38. Spits, H., J. Borst, M. Giphart, J. Coligan, C. Terhorst, and J. E. de Vries. 1984. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur. J. Immunol. 14:299.
39. Vandekerckhove, B. A. E., G. Datema, F. Koning, E. Goulmy, G. G. Persijn, J. J. van Rood, F. H. J. Claas, and J. E. de Vries. 1990. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. J. Immunol. 144:1288.
40. Peijnenburg, A., B. Godthelp, A. Van Boxel-Dezaire, and P. J. Van den Elsen. 1995. Definition of a novel complementation group in MHC class II deficiency. Immunogenetics 41:287.
41. Cleveland, D. W., M. A. Lopata, R. J. MacDonald, N. J. Cowan, W. J. Rutter, and M. W. Kirschner. 1980. Number and evolutionary conservation of α- and β-tubilin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95.
42. Verduyn, W., I. I. N. Doxiadis, J. Anholts, J. J. M. Drabbels, A. Naipal, J. D'Amaro, G. G. Persijn, M. J. Giphart, and G. M. Th. Schreuder. 1993. Biotinylated DRB sequence-specific oligonucleotides: comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum. Immunol. 37:59.
43. Kobr, M., W. Reith, C. Herrero-Sanchez, and B. Mach. 1990. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol. Cell. Biol. 10:965.
44. Sukiennicki, T. L., L. M. Shewey, and G. T. Nepom. 1993. Locus- and allele-specific DNA-protein interactions in the HLA-DQB1 X box. Immunol. Res. 12: 317.
45. Rigaud, G., F. Paiola, and R. S. Accolla. 1994. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator. Eur. J. Immunol. 24:2415.
46. Wright, K. L., K.-C. Chin, M. Linhoff, C. Skinner, J. A. Brown, J. M. Boss, G. R. Stark, and J. P.-Y. Ting. 1998. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA 95:6267.
47. Stunz, L. L., R. W. Karr, and R. A. Anderson. 1989. HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level. J. Immunol. 143: 3081.
48. Sloan, J. H., S. L. Hasegawa, and J. M. Boss. 1992. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J. Immunol. 148:2591.
49. Emery, P., B. Mach, and W. Reith. 1993. The different level of expression of HLA-DRB1 and HLA-DRB3 genes is controlled by conservative isotypic differences in promoter sequence. Hum. Immunol. 38:137.
50. Louis, P., R. Vincent, P. Cavadore, J. Clot, and J.-F. Eliaou. 1994. Differential transcriptional activities of HLA-DR genes in the various haplotypes. J. Immunol. 153:5059.
51. Singal, D. P., and X. Qiu. 1994. Polymorphism in the upstream regulatory region and level of expression of HLA-DRB genes. Mol. Immunol. 31:1117.
52. Beaty, J. S., K. A. West, and G. T. Nepom. 1995. Functional effects of natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1. Mol. Cell. Biol. 15:4771.
53. Singal, D. P., and X. Qiu. 1996. Polymorphism in both X and Y box motifs controls level of expression of HLA-DRB1 genes. Immunogenetics 43:50.
54. Morzycka-Wroblewska, E., A. Munshi, M. Ostermayer, J. I. Harwood, and M. F. Kagnoff. 1997. Differential expression of HLA-DQA1 alleles associated with promoter polymorphism. Immunogenetics 45:163.
55. Sugawara, M., P. D. Ponath, Z. Yang, and J. L. Strominger. 1992. Interferon-γ response region in the promoter of the class II MHC gene, DPA. Hum. Immunol. 35:157.
56. Karlsson, L., A. Peleraux, R. Lindstedt, M. Liljedahl, and P. A. Peterson. 1994. Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266:1569.
57. Lightstone, L., R. Hargreaves, G. Bobek, M. Peterson, G. Aichinger, G. Lombardi, and R. Lechler. 1997. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA 94:5772.
58. Maurer, D. H., J. H. Hanke, E. Mickelson, R. R. Rich, and M. S. Pollack. 1987. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-γ-treated dermal fibroblasts. J. Immunol. 139:715.
59. Maurer, D. H., C. Callaway, S. Sorkin, and M. S. Pollack. 1987. γ interferon induces detectable serological and functional expression of DR and DP but not DQ antigens on cultured amniotic fluid cells. Tissue Antigens 31:174.
60. Hauber, I., H. Gulle, H. M. Wolf, M. Maris, H. Eggenbauer, and M. M. Eibl. 1995. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. J. Exp. Med. 181:1411.
61. Douhan, J., III, I. Hauber, M. M. Eibl, and L. H. Glimcher. 1996. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D α and β chains. J. Exp. Med. 183:1063.
62. Douhan, J., III, R. Lieberson, J. H. M. Knoll, H. Zhou, and L. Glimcher. 1997. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J. Exp. Med. 185:1885.
63. Levine, F., and D. Pious. 1984. Revenants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression. J. Immunol. 132:959.
64. Clausen, B. E., J.-M. Waldburger, F. Schwenk, E. Barras, B. Mach, K. Rajewsky, I. Förster, and W. Reith. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8:143.
65. Wright, K. L., and J. P.-Y. Ting. 1992. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon-γ. Proc. Natl. Acad. Sci. USA 89:7601.
66. Wright, K. L., T. L. Moore, B. J. Vilen, A. M. Brown, and J. P.-Y. Ting. 1995. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Spl and NF-Y. J. Biol. Chem. 270:20978.